1-20 of 68
Min Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer

Available to Purchase
Min Wei, Xinping Huang, Liming Liao, Yonglu Tian, Xiaofeng Zheng
Journal: Cancer Research
Cancer Res (2023) 83 (17): 2908–2923.
https://doi.org/10.1158/0008-5472.CAN-22-4017
Published: 01 September 2023
View articletitled, SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Open the PDF for SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract P3-02-08: Diagnosis, navigation, treatment: A versatile biocompatible and biodegradable mesoporous silica platform of NIR II fluorescence imaging for early diagnosis, breast cancer precisely surgery, and radiosensitization

Free
Min Wei, Peiyuan Wang, Guojun Zhang
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P3-02-08.
https://doi.org/10.1158/1538-7445.SABCS21-P3-02-08
Published: 15 February 2022
View articletitled, Abstract P3-02-08: Diagnosis, navigation, treatment: A versatile biocompatible and biodegradable mesoporous silica platform of NIR II fluorescence imaging for early diagnosis, breast cancer precisely surgery, and radiosensitization
Journal Articles

Abstract 1854: A Fc-competent anti-human TIGIT blocking antibody BGB-A1217 elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models

Free
Xin Chen, Liu Xue, Xiao Ding, Qi Liu, Jing Zhang, Lei Jiang, Sha Liu, Hongjia Hou, Qing Zhu, Bin Jiang, Lijie Zhang, Xiaosui Zhou, Jie Ma, Yucheng Li, Wei Jin, Min Wei, Zhirong Shen, Mike Liu, Kang Li, Tong Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1854.
https://doi.org/10.1158/1538-7445.AM2021-1854
Published: 01 July 2021
View articletitled, Abstract 1854: A Fc-competent anti-human TIGIT blocking antibody BGB-A1217 elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models
Journal Articles

Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects

Free
Irene Caffa, Vanessa Spagnolo, Pamela Becherini, Francesca Valdemarin, Claudio Vernieri, Min Wei, Sebastian Brandhorst, Chiara Zucal, Else Driehuis, Lorenzo Ferrando, Luca Mastracci, Michele Cilli, Francesco Piacente, Anna Laura Cremonini, Mario Passalacqua, Valerio Vellone, Gabriele Zoppoli, Michele Cea, Giulia Salvadori, Salvatore Cortellino, Hans Clevers, Filippo De Braud, Alessandro Provenzani, Valter D. Longo, Alessio Nencioni
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT075.
https://doi.org/10.1158/1538-7445.AM2020-CT075
Published: 15 August 2020
View articletitled, Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects
Journal Articles

Abstract 6415: RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors

Free
Xi Yuan, Xinwen Zhang, Rong Du, Shing-Hu Cheung, Min Wei, Changyou Zhou, Lai Wang, Todd Shearer, Badreddin Edris, Mary Smith, Zhan Yao, Claire N. Thant, Neal Rosen, Lusong Luo
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6415.
https://doi.org/10.1158/1538-7445.AM2020-6415
Published: 15 August 2020
View articletitled, Abstract 6415: RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
Journal Articles

Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma

Available to Purchase
Min-Wei Yang, Ling-Ye Tao, Yong-Sheng Jiang, Jian-Yu Yang, Yan-Miao Huo, De-Jun Liu, Jiao Li, Xue-Liang Fu, Ruizhe He, Chaoyi Lin, Wei Liu, Jun-Feng Zhang, Rong Hua, Qing Li, Shu-Heng Jiang, Li-Peng Hu, Guang-Ang Tian, Xiao-Xin Zhang, Ningning Niu, Ping Lu, Juanjuan Shi, Gary G. Xiao, Li-Wei Wang, Jing Xue, Zhi-Gang Zhang, Yong-Wei Sun
Journal: Cancer Research
Cancer Res (2020) 80 (10): 1991–2003.
https://doi.org/10.1158/0008-5472.CAN-19-2689
Published: 15 May 2020
View articletitled, Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma
Open the PDF for Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 2368: The phosphatase PRL3 as a novel therapeutic target in acute lymphoblastic leukemia

Free
Anna K. O'Leary, Min Wei, Jessica Blackburn
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2368.
https://doi.org/10.1158/1538-7445.AM2018-2368
Published: 01 July 2018
View articletitled, Abstract 2368: The phosphatase PRL3 as a novel therapeutic target in acute lymphoblastic leukemia
Journal Articles

Abstract 2364: The phosphatase PRL-3 is a pro-survival oncogene in acute lymphoblastic leukemia

Free
Min Wei, Kristin O'Leary, Jinpeng Liu, Chi Wang, Jessica Blackburn
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2364.
https://doi.org/10.1158/1538-7445.AM2018-2364
Published: 01 July 2018
View articletitled, Abstract 2364: The phosphatase PRL-3 is a pro-survival oncogene in acute lymphoblastic leukemia
Journal Articles

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

Free
Weizhi He, Jinghua Wu, Juanjuan Shi, Yan-Miao Huo, Wentao Dai, Jing Geng, Ping Lu, Min-Wei Yang, Yuan Fang, Wei Wang, Zhi-Gang Zhang, Aida Habtezion, Yong-Wei Sun, Jing Xue
Journal: Cancer Research
Cancer Res (2018) 78 (12): 3293–3305.
https://doi.org/10.1158/0008-5472.CAN-17-3131
Published: 14 June 2018
View articletitled, IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer
Open the PDF for IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 5357: OncoGxSelectTM - a beneficial supplement to comprehensive cancer genetic test

Free
Yang Han, Pengfei Yu, Qingxuan Song, Min Wei, Guanghui Hu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5357.
https://doi.org/10.1158/1538-7445.AM2017-5357
Published: 01 July 2017
View articletitled, Abstract 5357: OncoGxSelectTM - a beneficial supplement to comprehensive cancer genetic test
Journal Articles

Abstract 2628: BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation

Free
Tong Zhang, Liu Xue, Jing Zhang, Qi Liu, Jie Ma, Yi Zhang, Yingdi Shi, Hongjia Hou, Hao Peng, Ning Liu, Yilu Zhang, Xiaomin Song, Yucheng Li, Jing Song, Lai Wang, Min Wei, Kang Li
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2628.
https://doi.org/10.1158/1538-7445.AM2017-2628
Published: 01 July 2017
View articletitled, Abstract 2628: BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation
Journal Articles

The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer

Free
Min-Wei Chen, Shu-Ting Yang, Ming-Hsien Chien, Kuo-Tai Hua, Chin-Jui Wu, S.M. Hsiao, Hao Lin, Michael Hsiao, Jen-Liang Su, Lin-Hung Wei
Journal: Cancer Research
Cancer Res (2017) 77 (8): 1955–1967.
https://doi.org/10.1158/0008-5472.CAN-16-1115
Published: 13 April 2017
View articletitled, The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer
Open the PDF for The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4698: BET protein inhibitors prevent TKI-induced drug resistance in solid tumors

Free
Yuan Zhao, Yiyuan Wu, Hexiang Wang, Bo Ren, Ye Liu, Min Wei, Changyou Zhou, Lusong Luo
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4698.
https://doi.org/10.1158/1538-7445.AM2016-4698
Published: 15 July 2016
View articletitled, Abstract 4698: BET protein inhibitors prevent TKI-induced drug resistance in solid tumors
Journal Articles

Abstract 1230: BGB-283: a novel RAF Dimer inhibitor, displays potent antitumor activity in HCC patient derived xenograft models

Free
Zhiyu Tang, Yong Liu, Beibei Jiang, Yajuan Gao, Wenfeng Gong, Xing Wang, Dan Su, Fenglong Yu, Ye Liu, Min Wei, Lai Wang
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1230.
https://doi.org/10.1158/1538-7445.AM2016-1230
Published: 15 July 2016
View articletitled, Abstract 1230: BGB-283: a novel RAF Dimer inhibitor, displays potent antitumor activity in HCC patient derived xenograft models
Journal Articles

Abstract 2226: Anti-human PD-1 antibody BGB-A317 exhibits potent immune cell activation

Free
Tong Zhang, Jing Song, Yucheng Li, Jie Ma, Yingdi Shi, Xiaoran Wu, Lanlan Xu, Qi Liu, Yanping Cao, Yali Wang, Hao Peng, Hongjia Hou, Xu Zhao, Xiaomin Song, Lai Wang, Min Wei, Lusong Luo, Kang Li
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2226.
https://doi.org/10.1158/1538-7445.AM2016-2226
Published: 15 July 2016
View articletitled, Abstract 2226: Anti-human PD-1 antibody BGB-A317 exhibits potent immune cell activation
Journal Articles

Abstract 342: BGB-283, a slow-off inhibitor of RAF dimers, differentiates from vemurafenib in MAPK signaling inhibition

Free
Ye Liu, Xi Yuan, Zhiyu Tang, Lai Wang, Lusong Luo, Min Wei
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 342.
https://doi.org/10.1158/1538-7445.AM2016-342
Published: 15 July 2016
View articletitled, Abstract 342: BGB-283, a slow-off inhibitor of RAF dimers, differentiates from vemurafenib in MAPK signaling inhibition
Journal Articles

Abstract 3633: OncoGxOneTM - an advanced genomic test for precision cancer treatment

Free
Yang Han, Pengfei Yu, Qingxuan Song, Min Wei, Guanghui Hu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3633.
https://doi.org/10.1158/1538-7445.AM2016-3633
Published: 15 July 2016
View articletitled, Abstract 3633: OncoGxOneTM - an advanced genomic test for precision cancer treatment
Journal Articles

Abstract 4313: Periodic fasting mimicking diet delays cancer development and progression

Free
Sebastian Brandhorst, Gerardo Navarrete, Min Wei, Todd E. Morgan, Valter D. Longo
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4313.
https://doi.org/10.1158/1538-7445.AM2016-4313
Published: 15 July 2016
View articletitled, Abstract 4313: Periodic fasting mimicking diet delays cancer development and progression
Journal Articles

Abstract 1651: BGB-290, a novel PARP inhibitor with unique brain penetration ability, demonstrated strong synergism with temozolomide in subcutaneous and intracranial xenograft models

Free
Zhiyu Tang, Bin Jiang, Zhenyan Shi, Wenfeng Gong, Yong Liu, Xing Wang, Yajuan Gao, Fenglong Yu, Changyou Zhou, Lusong Luo, Min Wei, Lai Wang
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1651.
https://doi.org/10.1158/1538-7445.AM2015-1651
Published: 01 August 2015
View articletitled, Abstract 1651: BGB-290, a novel PARP inhibitor with unique brain penetration ability, demonstrated strong synergism with temozolomide in subcutaneous and intracranial xenograft models
Journal Articles

Abstract 1653: BGB-290: A highly potent and specific PARP1/2 inhibitor potentiates anti-tumor activity of chemotherapeutics in patient biopsy derived SCLC models

Free
Zhiyu Tang, Ye Liu, Qin Zhen, Bo Ren, Hexiang Wang, Zhenyan Shi, Wenfeng Gong, Yong Liu, Xing Wang, Yajuan Gao, Fenglong Yu, Yiyuan Wu, Bing Jiang, Xuebing Sun, Min Wei, Changyou Zhou, Lusong Luo, Zhengxiang Li, Jiangyong Yu, Jun Zhao, Jie Wang, Lai Wang
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1653.
https://doi.org/10.1158/1538-7445.AM2015-1653
Published: 01 August 2015
View articletitled, Abstract 1653: BGB-290: A highly potent and specific PARP1/2 inhibitor potentiates anti-tumor activity of chemotherapeutics in patient biopsy derived SCLC models